Volume4, Issue0 (2018)

Volume

Table of Contents (149 articles)

Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an adult woman: review of imaging, literature and management

Ankit Mehta, ... Lynn G. Feun

Prediction of post-progression survival in patients with advanced hepatocellular carcinoma treated with sorafenib by using time-dependent changes in clinical characteristics

Yoshiyuki Wada

, ... Hideki Saitsu

Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum

Federica Buonfiglioli, ... Stefano Brillanti

Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort

Scott T. Nishioka, ... Sandi A. Kwee

Hepatocellular carcinoma in the setting of interferon-free treatment for chronic HCV hepatitis - experience of a single center

Elena Laura Iliescu

, ... Daniel Rusie

Treatment of high-burden hepatocellular carcinoma: an oncologist perspective

Landon L. Chan, ... Stephen L. Chan

Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of primary liver cancer

Tao-Yang Chen, ... Hong Tu

Comparison of outcomes between laparoscopic vs. open liver resection for intermediate stage hepatocellular carcinoma

Avril David, ... Jai Young Cho

Lycopene treatment stalls the onset of experimentally induced hepatocellular carcinoma: a radioisotopic, physiological and biochemical analysis

Nisha Bhatia, ... Ashwani Koul

[¹⁸F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular carcinoma model treated with sorafenib

Fernando Gomes de Barros Costa

, ... Claudia P. Oliveira

Beta2-glycoprotein I cooperate with hepatitis B surface antigen promotes hepatocellular carcinogenesis via the nuclear factor kappa B signal pathway were enhanced by the lipopolysaccharide

Xue-Li Ding, ... Ya-Nan Yu

Pre-S2 and HBV associated hepatocellular carcinoma

Ying Zheng, ... Hong Fan

Surveillance for hepatocellular carcinoma - current status and advances

Kaina Chen, ... Chee-Kiat Tan

Hepatocellular carcinoma in patients without cirrhosis: relevance and clinical characteristics

Kellyane Santana Dias Carvalho, ... Helma P. Cotrim

New strategy to distinguish clonal origin of RHCC/MHCC between intrahepatic metastasis and multicentric occurrence

Han Wang, ... Wen-Ming Cong

A potential clinical based score in hepatitis C virus cirrhotic patients to exclude small hepatocellular carcinoma

Denise Cerqueira Paranaguá-Vezozzo

, ... Flair José Carrilho

Understanding the inflammation-cancer transformation in the development of primary liver cancer

Hong-Jin Chen, ... Hong-Ping Xia

Chitinase-3-like protein 1 as a predictor for the progression or regression of liver fibrosis

Biaoyang Lin, ... Saadiya Mushtaq

Neoadjuvant hepatic arterial infusion chemotherapy for resectable hepatocellular carcinomas

Rina Tsutsui, ... Jun Akiba

Systemic therapies for hepatocellular carcinoma: a recap of the current status

Petros Giovanis

, ... Davide Pastorelli

Ablative techniques in hepatocellular carcinoma treatment

Ehsun Naeem, ... Shahab Abid

Molecular mechanism of hepatocellular carcinoma

Seung Kew Yoon

Expression quantitative trait loci for PVT1 contributes to the prognosis of hepatocellular carcinoma

Ting Tian, ... Zhi-Bin Hu

Molecular targeting of antiviral drugs used against hepatitis C virus infection

Mohammad Irshad

, ... Khushboo Irshad

Factors predicting hepatocellular carcinoma in hepatitis C infection

Zaigham Abbas

, ... Minaam Abbas

Hypoxic microenvironment and hepatocellular carcinoma treatment

Ci-Ai Lin, ... Bo Yang

Oxidative stress and hepatocarcinogenesis

Ying Fu

, ... Fung-Lung Chung

Heat shock reduces HCV replication via regulation of ribosomal L22 in Alu-RNA molecule dependent manner

Hamada Farghaly, ... Hany Khalil

Efficacy and safety of generic daclatasvir + sofosbuvir ± ribavirin in treatment of genotype 3 infected hepatitis C patients - a real life experience from Pakistan

Muhammad Umar

, ... Shoaib Khokhar

Oncogenic Wnt3a: a promising specific biomarker in hepatocellular carcinoma

Min Yao, ... Deng-Fu Yao

Somatostatin in hepatocellular carcinoma: experimental and therapeutic implications

Elias Kouroumalis

, ... George Notas

The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma

Saranya Chidambaranathan-Reghupaty, ... Devanand Sarkar

HCV-discovery to elimination, “myth or reality”

Wasim Jafri

, ... Safia Awan

Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease

Riccardo Nevola, ... Luigi Elio Adinolfi

Aberrant pre-mRNA splicing regulation in the development of hepatocellular carcinoma

Supriya Sen

Staging of hepatocellular carcinoma

Sedat Karademir

The fibroblast growth factor receptor pathway in hepatocellular carcinoma

Joycelyn Jie Xin Lee, ... Su Pin Choo

Pathway analysis provides insight into the genetic susceptibility to hepatocellular carcinoma and insight into immuno-therapy treatment response

Yih-Kuang Lu, ... Kenneth Howard Buetow

Immunotherapy: a new era for hepatocellular carcinoma

Ya-Jing He, ... Jin-Lin Hou

Intrahepatic cholangiocarcinoma: review and update

Vincenzo Cardinale, ... Domenico Alvaro

Mitoepigenetics and hepatocellular carcinoma

María Guadalupe Lozano-Rosas, ... Victoria Chagoya de Sánchez

Screening for hepatocellular carcinoma: summary of current guidelines up to 2018

Nevin Yilmaz

, ... Nedim Cakir

Pro-oncogenic role of SerpinB3 in hepatocellular carcinoma

Andrea Martini, ... Patrizia Pontisso

Fat and hepatocellular carcinoma

Clara Balsano

, ... Simona Tavolaro

HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: still an issue?

Francesco Paolo Russo, ... Fabio Farinati

HCV elimination: breaking down the barriers to prison based care

Timothy Papaluca, ... Alexander Thompson

Hepatitis C related hepatocellular carcinoma in the era of direct-acting antivirals

Akshata Moghe, ... Obaid S. Shaikh

T cell immunotherapy in hepatitis B virus related hepatocellular carcinoma

Morteza Hafezi, ... Anthony T. Tan

Thermal ablation of large unresectable hepatocellular carcinoma in cirrhotic patients

Giovan Giuseppe Di Costanzo

, ... Marco Guarracino

Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries

Suna Yapali

, ... Nurdan Tozun

Elimination of hepatitis from Pakistan by 2030: is it possible?

Yasir Waheed

, ... Masood Siddiq

Exosome-based liquid biopsy in the management of hepatocellular carcinoma

Aparna Jayachandran

, ... Darrell H. G. Crawford

Performance of different biomarkers for the management of hepatocellular carcinoma

Ángela Rojas, ... Manuel Romero-Gómez

Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation

Evangelia M. Fatourou, ... Michael A. Heneghan

New insights on hepatocellular carcinoma: epidemiology and clinical aspects

Claudio Puoti

Hepatic resection for hepatocellular carcinoma

Shun Yamaguchi, ... Susumu Eguchi

Living donor liver transplantation for patients with hepatocellular carcinoma in Japan

Yasuhiko Sugawara

, ... Taizo Hibi

Adult African Americans undergoing cadaveric liver transplantation for hepatocellular carcinoma within the Milan criteria have the lowest 5-year survival among all the ethnic groups in the United States: analysis of USA national data between January 2002 and June 2013

Michele Molinari

, ... Naudia Jonaissaint

Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor

Gabriele Missale

, ... Elisabetta Cariani

Role of the contrast-enhanced ultrasoud in the diagnosis of HCC in cirrhotic liver

Francesco Loria

, ... Salvatore Giuseppe Galea

New and old biomarkers of hepatocellular carcinoma

Georgios Zacharakis

, ... Khaled K Aldossari

Cancer immunotherapy for hepatocellular carcinoma

Joo-Ho Lee, ... Naoshi Nishida

Laparoscopic liver resection for hepatocellular carcinoma

Massimo Giacca, ... Daniel Cherqui

Novel diagnosis and therapy for hepatoma targeting HBV-related carcinogenesis through alternative splicing of FIR (PUF60)/FIRΔexon2

Kazuyuki Matsushita

, ... Tyuji Hoshino

Hypofractionated ablative radiation therapy for hepatocellular carcinoma: practical considerations and review of the literature

Marsha Reyngold, ... Christopher H. Crane

Liver transplantation for hepatocellular carcinoma - non-cancer factors and implications for improving outcome beyond standard tumor criteria

Arno Kornberg

, ... Martina Schernhammer

Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation

Eric M. Wu, ... Sumodh Kalathil

Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our experience

Marialuisa Lugaresi

, ... Bruno Nardo

Quantitative hepatitis B surface antigen in predicting recurrence of hepatitis B-related hepatocellular carcinoma after liver transplantation

James Fung

, ... Chung-Mau Lo

Simple screening method for the diagnosis of nonB-nonC hepatocellular carcinoma

Kazuhiro Nouso

, ... Hiroyuki Okada

Direct-acting antivirals and chronic hepatitis C: towards elimination

Ricardo A. Franco

, ... Michael S. Saag

Minimally invasive therapies for hepatocellular carcinoma: narrowing the gaps

Kevin M. Sullivan, ... Raymond S. Yeung

Stemness features in liver cancer

Margherita Correnti, ... Fabio Marra

The prediction of microvascular invasion of hepatocellular carcinoma using multiple imaging modalities

Hideyuki Tamai

The prediction of microvascular invasion of hepatocellular carcinoma using multiple imaging modalities

Hideyuki Tamai

Direct-acting antivirals and chronic hepatitis C: towards elimination

Ricardo A. Franco

, ... Michael S. Saag

Simple screening method for the diagnosis of nonB-nonC hepatocellular carcinoma

Kazuhiro Nouso

, ... Hiroyuki Okada

Surveillance for hepatocellular carcinoma - current status and advances

Kaina Chen, ... Chee-Kiat Tan

Efficacy and safety of generic daclatasvir + sofosbuvir ± ribavirin in treatment of genotype 3 infected hepatitis C patients - a real life experience from Pakistan

Muhammad Umar

, ... Shoaib Khokhar

Direct-acting antivirals and hepatocellular carcinoma occurrence and recurrence in hepatitis C virus-related liver cirrhosis: fact or fiction

Alberto Zanetto, ... Patrizia Burra

Stemness features in liver cancer

Margherita Correnti, ... Fabio Marra

Minimally invasive therapies for hepatocellular carcinoma: narrowing the gaps

Kevin M. Sullivan, Raymond S. Yeung

Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our experience

Marialuisa Lugaresi

, ... Bruno Nardo

Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation

Eric M. Wu, ... Sumodh Kalathil

New and old biomarkers of hepatocellular carcinoma

Georgios Zacharakis

, ... Khaled K Aldossari

HCV elimination: breaking down the barriers to prison based care

Timothy Papaluca, Alexander Thompson

Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation

Evangelia M. Fatourou, ... Michael A. Heneghan

Quantitative hepatitis B surface antigen in predicting recurrence of hepatitis B-related hepatocellular carcinoma after liver transplantation

James Fung

, ... Chung-Mau Lo

Novel diagnosis and therapy for hepatoma targeting HBV-related carcinogenesis through alternative splicing of FIR (PUF60)/FIRΔexon2

Kazuyuki Matsushita

, Tyuji Hoshino

Liver transplantation for hepatocellular carcinoma - non-cancer factors and implications for improving outcome beyond standard tumor criteria

Arno Kornberg

, Martina Schernhammer

Role of the contrast-enhanced ultrasoud in the diagnosis of HCC in cirrhotic liver

Francesco Loria

, ... Salvatore Giuseppe Galea

Staging of hepatocellular carcinoma

Sedat Karademir

New insights on hepatocellular carcinoma: epidemiology and clinical aspects

Claudio Puoti

Adult African Americans undergoing cadaveric liver transplantation for hepatocellular carcinoma within the Milan criteria have the lowest 5-year survival among all the ethnic groups in the United States: analysis of USA national data between January 2002

Michele Molinari

, ... Naudia Jonaissaint

Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease

Riccardo Nevola, ... Luigi Elio Adinolfi

HCV-discovery to elimination, “myth or reality”

Wasim Jafri

, ... Safia Awan

Thermal ablation of large unresectable hepatocellular carcinoma in cirrhotic patients

Giovan Giuseppe Di Costanzo

, ... Marco Guarracino

The fibroblast growth factor receptor pathway in hepatocellular carcinoma

Joycelyn Jie Xin Lee, Su Pin Choo

Cancer immunotherapy for hepatocellular carcinoma

Joo-Ho Lee, ... Naoshi Nishida

Hepatic resection for hepatocellular carcinoma

Shun Yamaguchi, ... Susumu Eguchi

Hypofractionated ablative radiation therapy for hepatocellular carcinoma: practical considerations and review of the literature

Marsha Reyngold, ... Christopher H. Crane

Chitinase-3-like protein 1 as a predictor for the progression or regression of liver fibrosis

Biaoyang Lin, ... Saadiya Mushtaq

Laparoscopic liver resection for hepatocellular carcinoma

Massimo Giacca, Daniel Cherqui

Screening for hepatocellular carcinoma: summary of current guidelines up to 2018

Nevin Yilmaz

, ... Nedim Cakir

Elimination of hepatitis from Pakistan by 2030: is it possible?

Yasir Waheed

, Masood Siddiq

Exosome-based liquid biopsy in the management of hepatocellular carcinoma

Aparna Jayachandran

, ... Darrell H. G. Crawford

Factors predicting hepatocellular carcinoma in hepatitis C infection

Zaigham Abbas

, Minaam Abbas

Molecular mechanism of hepatocellular carcinoma

Seung Kew Yoon

Heat shock reduces HCV replication via regulation of ribosomal L22 in Alu-RNA molecule dependent manner

Hamada Farghaly, ... Hany Khalil

Immunotherapy: a new era for hepatocellular carcinoma

Ya-Jing He, ... Jin-Lin Hou

Oxidative stress and hepatocarcinogenesis

Ying Fu

, Fung-Lung Chung

Fat and hepatocellular carcinoma

Clara Balsano

, ... Simona Tavolaro

Aberrant pre-mRNA splicing regulation in the development of hepatocellular carcinoma

Supriya Sen

Hepatitis C related hepatocellular carcinoma in the era of direct-acting antivirals

Akshata Moghe, Obaid S. Shaikh

[¹⁸F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular carcinoma model treated with sorafenib

Fernando Gomes de Barros Costa

, ... Claudia P. Oliveira

Somatostatin in hepatocellular carcinoma: experimental and therapeutic implications

Elias Kouroumalis

, ... George Notas

Living donor liver transplantation for patients with hepatocellular carcinoma in Japan

Yasuhiko Sugawara

, ... Taizo Hibi

The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma

Saranya Chidambaranathan-Reghupaty, ... Devanand Sarkar

Performance of different biomarkers for the management of hepatocellular carcinoma

Ángela Rojas, ... Manuel Romero-Gómez

Oncogenic Wnt3a: a promising specific biomarker in hepatocellular carcinoma

Min Yao, ... Deng-Fu Yao

Understanding the inflammation-cancer transformation in the development of primary liver cancer

Hong-Jin Chen, ... Hong-Ping Xia

Pro-oncogenic role of SerpinB3 in hepatocellular carcinoma

Andrea Martini, Patrizia Pontisso

Expression quantitative trait loci for PVT1 contributes to the prognosis of hepatocellular carcinoma

Ting Tian, ... Zhi-Bin Hu

Hypoxic microenvironment and hepatocellular carcinoma treatment

Ci-Ai Lin, ... Bo Yang

HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: still an issue?

Francesco Paolo Russo, ... Fabio Farinati

Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries

Suna Yapali

, Nurdan Tozun

Molecular targeting of antiviral drugs used against hepatitis C virus infection

Mohammad Irshad

, ... Khushboo Irshad

Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor

Gabriele Missale

, Elisabetta Cariani

Pathway analysis provides insight into the genetic susceptibility to hepatocellular carcinoma and insight into immuno-therapy treatment response

Yih-Kuang Lu, ... Kenneth Howard Buetow

Intrahepatic cholangiocarcinoma: review and update

Vincenzo Cardinale, ... Domenico Alvaro

Mitoepigenetics and hepatocellular carcinoma

María Guadalupe Lozano-Rosas, ... Victoria Chagoya de Sánchez

Ablative techniques in hepatocellular carcinoma treatment

Ehsun Naeem, Shahab Abid

Pre-S2 and HBV associated hepatocellular carcinoma

Ying Zheng, ... Hong Fan

T cell immunotherapy in hepatitis B virus related hepatocellular carcinoma

Morteza Hafezi, ... Anthony T. Tan

Hepatocellular carcinoma in patients without cirrhosis: relevance and clinical characteristics

Kellyane Santana Dias Carvalho, ... Helma P. Cotrim

New strategy to distinguish clonal origin of RHCC/MHCC between intrahepatic metastasis and multicentric occurrence

Han Wang, Wen-Ming Cong

Neoadjuvant hepatic arterial infusion chemotherapy for resectable hepatocellular carcinomas

Rina Tsutsui, ... Jun Akiba

Beta2-glycoprotein I cooperate with hepatitis B surface antigen promotes hepatocellular carcinogenesis via the nuclear factor kappa B signal pathway were enhanced by the lipopolysaccharide

Xue-Li Ding, ... Ya-Nan Yu

A potential clinical based score in hepatitis C virus cirrhotic patients to exclude small hepatocellular carcinoma

Denise Cerqueira Paranaguá-Vezozzo

, ... Flair José Carrilho

Systemic therapies for hepatocellular carcinoma: a recap of the current status

Petros Giovanis

, ... Davide Pastorelli

Lycopene treatment stalls the onset of experimentally induced hepatocellular carcinoma: a radioisotopic, physiological and biochemical analysis

Nisha Bhatia, ... Ashwani Koul

Prediction of post-progression survival in patients with advanced hepatocellular carcinoma treated with sorafenib by using time-dependent changes in clinical characteristics

Yoshiyuki Wada

, ... Hideki Saitsu

Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an adult woman: review of imaging, literature and management

Ankit Mehta, ... Lynn G. Feun

Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum

Federica Buonfiglioli, Stefano Brillanti

Treatment of high-burden hepatocellular carcinoma: an oncologist perspective

Landon L. Chan, Stephen L. Chan

Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of primary liver cancer

Tao-Yang Chen, ... Hong Tu

Hepatocellular carcinoma in the setting of interferon-free treatment for chronic HCV hepatitis - experience of a single center

Elena Laura Iliescu

, ... Daniel Rusie

Comparison of outcomes between laparoscopic vs. open liver resection for intermediate stage hepatocellular carcinoma

Avril David, ... Jai Young Cho

Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort

Scott T. Nishioka, ... Sandi A. Kwee

Volume

Table of Contents (149 articles)

Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an adult woman: review of imaging, literature and management

Prediction of post-progression survival in patients with advanced hepatocellular carcinoma treated with sorafenib by using time-dependent changes in clinical characteristics

Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum

Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort

Hepatocellular carcinoma in the setting of interferon-free treatment for chronic HCV hepatitis - experience of a single center

Treatment of high-burden hepatocellular carcinoma: an oncologist perspective

Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of primary liver cancer

Comparison of outcomes between laparoscopic vs. open liver resection for intermediate stage hepatocellular carcinoma

Lycopene treatment stalls the onset of experimentally induced hepatocellular carcinoma: a radioisotopic, physiological and biochemical analysis

[18F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular carcinoma model treated with sorafenib

Beta2-glycoprotein I cooperate with hepatitis B surface antigen promotes hepatocellular carcinogenesis via the nuclear factor kappa B signal pathway were enhanced by the lipopolysaccharide

Pre-S2 and HBV associated hepatocellular carcinoma

Surveillance for hepatocellular carcinoma - current status and advances

Hepatocellular carcinoma in patients without cirrhosis: relevance and clinical characteristics

New strategy to distinguish clonal origin of RHCC/MHCC between intrahepatic metastasis and multicentric occurrence

A potential clinical based score in hepatitis C virus cirrhotic patients to exclude small hepatocellular carcinoma

Understanding the inflammation-cancer transformation in the development of primary liver cancer

Chitinase-3-like protein 1 as a predictor for the progression or regression of liver fibrosis

Neoadjuvant hepatic arterial infusion chemotherapy for resectable hepatocellular carcinomas

Systemic therapies for hepatocellular carcinoma: a recap of the current status

Ablative techniques in hepatocellular carcinoma treatment

Molecular mechanism of hepatocellular carcinoma

Expression quantitative trait loci for PVT1 contributes to the prognosis of hepatocellular carcinoma

Molecular targeting of antiviral drugs used against hepatitis C virus infection

Factors predicting hepatocellular carcinoma in hepatitis C infection

Hypoxic microenvironment and hepatocellular carcinoma treatment

Oxidative stress and hepatocarcinogenesis

Heat shock reduces HCV replication via regulation of ribosomal L22 in Alu-RNA molecule dependent manner

Efficacy and safety of generic daclatasvir + sofosbuvir ± ribavirin in treatment of genotype 3 infected hepatitis C patients - a real life experience from Pakistan

Oncogenic Wnt3a: a promising specific biomarker in hepatocellular carcinoma

Somatostatin in hepatocellular carcinoma: experimental and therapeutic implications

The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma

HCV-discovery to elimination, “myth or reality”

Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease

Aberrant pre-mRNA splicing regulation in the development of hepatocellular carcinoma

Staging of hepatocellular carcinoma

The fibroblast growth factor receptor pathway in hepatocellular carcinoma

Pathway analysis provides insight into the genetic susceptibility to hepatocellular carcinoma and insight into immuno-therapy treatment response

Immunotherapy: a new era for hepatocellular carcinoma

Intrahepatic cholangiocarcinoma: review and update

Mitoepigenetics and hepatocellular carcinoma

Screening for hepatocellular carcinoma: summary of current guidelines up to 2018

Pro-oncogenic role of SerpinB3 in hepatocellular carcinoma

Fat and hepatocellular carcinoma

HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: still an issue?

HCV elimination: breaking down the barriers to prison based care

Hepatitis C related hepatocellular carcinoma in the era of direct-acting antivirals

T cell immunotherapy in hepatitis B virus related hepatocellular carcinoma

Thermal ablation of large unresectable hepatocellular carcinoma in cirrhotic patients

Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries

Elimination of hepatitis from Pakistan by 2030: is it possible?

Exosome-based liquid biopsy in the management of hepatocellular carcinoma

Performance of different biomarkers for the management of hepatocellular carcinoma

Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation

New insights on hepatocellular carcinoma: epidemiology and clinical aspects

Hepatic resection for hepatocellular carcinoma

Living donor liver transplantation for patients with hepatocellular carcinoma in Japan

Adult African Americans undergoing cadaveric liver transplantation for hepatocellular carcinoma within the Milan criteria have the lowest 5-year survival among all the ethnic groups in the United States: analysis of USA national data between January 2002 and June 2013

Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor

Role of the contrast-enhanced ultrasoud in the diagnosis of HCC in cirrhotic liver

New and old biomarkers of hepatocellular carcinoma

Cancer immunotherapy for hepatocellular carcinoma

Laparoscopic liver resection for hepatocellular carcinoma

Novel diagnosis and therapy for hepatoma targeting HBV-related carcinogenesis through alternative splicing of FIR (PUF60)/FIRΔexon2

Hypofractionated ablative radiation therapy for hepatocellular carcinoma: practical considerations and review of the literature

Liver transplantation for hepatocellular carcinoma - non-cancer factors and implications for improving outcome beyond standard tumor criteria

Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation

Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our experience

Quantitative hepatitis B surface antigen in predicting recurrence of hepatitis B-related hepatocellular carcinoma after liver transplantation

Simple screening method for the diagnosis of nonB-nonC hepatocellular carcinoma

Direct-acting antivirals and chronic hepatitis C: towards elimination

Minimally invasive therapies for hepatocellular carcinoma: narrowing the gaps

Stemness features in liver cancer

The prediction of microvascular invasion of hepatocellular carcinoma using multiple imaging modalities

The prediction of microvascular invasion of hepatocellular carcinoma using multiple imaging modalities

Direct-acting antivirals and chronic hepatitis C: towards elimination

Simple screening method for the diagnosis of nonB-nonC hepatocellular carcinoma

Surveillance for hepatocellular carcinoma - current status and advances

[¹⁸F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular carcinoma model treated with sorafenib

[¹⁸F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular carcinoma model treated with sorafenib